Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Per Stirling Capital Management increased its stake in the First Trust Smith Opportunistic Fixed Income ETF (FIXD) by...
Nuclear energy has moved from niche to core in many energy plans. This guide breaks down the best nuclear energy stoc...
A practical comparison of Corning and QuantumScape for 2026. Learn where each stock shines, the risks you should watc...
Two chipmakers lit up the market in the first half of 2026, but the big question remains: which is the smarter buy no...
SpaceX faces another setback as a Starship test ends without a successful launch. This article breaks down the implic...
Ethereum has seen price swings as reports surface that ethereum founder vitalik buterin has been selling portions of ...
Silver has cooled after a sharp rally, but the path ahead remains uncertain. This guide breaks down why silver down f...
Nuclear energy is attracting new attention from investors. This guide compares NuScale Power and Constellation Energy...
A tiny stock with a big frontier, D-Wave has captured headlines as its shares rally. This article breaks down what ha...
This week’s rally in First Solar stock is turning heads. We break down the catalysts, assess risks, and offer practic...
Two very different retail giants compete for investors' attention in 2026. This guide breaks down whether Abercrombie...